Clinical Trial Update: Single Visit Clinical Validation of ScreenFire, a Low-Cost HPV Test: Efficacy and Cost Effectiveness (Phase 2) [NA]

View source ↗

Summary

Phase 2 clinical validation study of ScreenFire, a low-cost HPV test for cervical cancer screening, is described, with the trial status NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: The Cleveland Clinic | Conditions: Cervical Cancer Screening | NA | Status: NOT_YET_RECRUITING